2010
DOI: 10.1016/j.mpdhp.2010.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Mesenteric solitary fibrous tumour containing metastasis from breast carcinoma: an unusual example of tumour to tumour metastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…While SFT has been acknowledged as a suitable niche for harboring metastases because of its rich vascularity to lter microemboli from other tumors, SFT is an extraordinarily rare recipient for tumor-to-tumor metastasis. To date, only nine SFT recipients of tumor-to-tumor metastasis have been described in the literature (Table 1), including ve intrathoracic lesions, one intraabdominal, one spinal intradural, and two in the soft tissues (thigh and back) [2][3][4][5][6][7][8][9][10]. The most common metastatic donor to SFT in previous reports was breast cancer.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…While SFT has been acknowledged as a suitable niche for harboring metastases because of its rich vascularity to lter microemboli from other tumors, SFT is an extraordinarily rare recipient for tumor-to-tumor metastasis. To date, only nine SFT recipients of tumor-to-tumor metastasis have been described in the literature (Table 1), including ve intrathoracic lesions, one intraabdominal, one spinal intradural, and two in the soft tissues (thigh and back) [2][3][4][5][6][7][8][9][10]. The most common metastatic donor to SFT in previous reports was breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Solitary brous tumor (SFT) is an extraordinarily rare recipient for tumor-to-tumor metastasis. So far, there are only nine recipients of SFT described in the literature [2][3][4][5][6][7][8][9][10]. The most common metastatic donor to an SFT is breast cancer, while prostatic carcinoma acting as a donor tumor has not been previously reported.…”
Section: Introductionmentioning
confidence: 99%